C-RVV

C:RVV - Revive Therapeutics Ltd. - https://www.revivethera.com

04:26:54 EST

Sym-X	Bid - Ask					Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
RVV - C	611.0	0.01	·	0.015	1408.7	0.015	+0.005	50.0	1,568.7	16	29	0.01 0.015 0.01	0.035 0.005	15:59:56	Dec 15	15 min RT 2¢
CSE - C	611.0	0.01	·	0.015	1408.7	0.01			1,377.2	14	15	0.01 0.015 0.01	0.035 0.005	14:26:20		15 min
NEO ATS - U						0.01			106.0	1	9	0.01 0.015 0.01		14:30:08		15 min
Omega - O						0.015	+0.005	50.0	80.0	1	2	0.015 0.015 0.015		15:59:56		15 min
CX2 - H						0.01			1.0		1	0.01 0.01 0.01		10:00:53		15 min
MatchNOW - M						0.01			0.5		1			Sep 08/20		15 min
CS2 - S						0.015	+0.005	50.0	4.0		1	0.015 0.015 0.015		14:35:54		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 2 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Shorts · Portfolio

Recent Trades - Last 10 of 29

More trades...

Time ET	Ex	Price	Change	Volume	Buyer	Seller	Markers
15:59:56	O	0.015	0.005	50,000	1 Anonymous	1 Anonymous	K
14:35:54	S	0.015	0.005	4,000	7 TD Sec	1 Anonymous	K
14:30:08	U	0.01		2,000	1 Anonymous	80 National Bank	K
14:30:08	U	0.01		2,000	1 Anonymous	80 National Bank	K
14:26:20	M	0.01		500	2 RBC	1 Anonymous	E
14:26:20	C	0.01		3,000	2 RBC	2 RBC	K
11:41:20	C	0.01		50,000	19 Desjardins	2 RBC	K
11:39:09	O	0.015	0.005	30,000	2 RBC	1 Anonymous	K
11:25:12	U	0.015	0.005	50,000	2 RBC	1 Anonymous	K
11:25:12	C	0.015	0.005	40,000	2 RBC	2 RBC	K

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins

News ReleasesIn The NewsOther

Date ET	Symbol	Price	Type	Headline
2025-12-15 17:09	C:RVV	0.015	News Release200	Revive Therapeutics primes the pump on Bucillamine
2025-11-28 17:31	C:RVV	0.01	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-11-28 17:24	C:RVV	0.01	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-11-21 16:56	C:RVV	0.01	News Release200	Revive talks DRDC study on bucillamine for nerve agents
2025-10-28 18:43	C:RVV	0.015	SEDAR MD & A815	SEDAR MD & A
2025-10-28 18:37	C:RVV	0.015	SEDAR Audited Annual Financial Statements804	SEDAR Audited Annual Financial Statements
2025-09-19 17:21	C:RVV	0.015	News Release200	Revive Therapeutics closes second tranche of financing
2025-09-05 19:58	C:RVV	0.02	News Release200	Revive extends $650,000 private placement
2025-08-11 19:43	C:RVV	0.02	News Release200	Revive closes $60,900 first tranche of placement
2025-07-31 02:33	C:RVV	0.015	News Release200	Revive Therapeutics arranges financing, debt settlement
2025-07-08 22:22	C:RVV	0.02	News Release200	Revive has no future plans yet with Defence R&D
2025-06-26 17:33	C:RVV	0.02	News Release200	Revive hopes to conclude bucillamine study by September
2025-06-04 16:14	C:RVV	0.03	News Release200	Revive develops new bucillamine formulation
2025-05-29 22:05	C:RVV	0.025	SEDAR Interim Financial Statements812	SEDAR Interim Financial Statements
2025-05-29 22:05	C:RVV	0.025	SEDAR Interim MD & A813	SEDAR Interim MD & A
2025-05-12 19:10	C:RVV	0.03	News Release200	Revive's bucillamine research study to end by June
2025-04-21 17:06	C:RVV	0.03	News Release200	Revive Therapeutics to settle $150,000 debt with shares
2025-04-10 13:52	C:RVV	0.02	News Release200	Revive to study bucillamine as cancer treatment
2025-04-01 16:35	C:RVV	0.015	News Release200	Revive agrees to buy Diagnamed's molecular hydrogen IP
2025-03-19 17:28	C:RVV	0.01	News Release200	Revive shareholders approve all matters at AGSM